Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",19019,152,1.50 [1.10-2.05],0.0109744690651248
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",19994,205,1.43 [1.08-1.90],0.0133366967871182
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",19761,1440,1.33 [1.19-1.49],7.300244165067865e-07
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Candidiasis,20009,452,1.40 [1.16-1.71],0.0006106660501679
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,19353,3530,1.27 [1.18-1.37],8.599689632664881e-10
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),19328,3585,1.33 [1.24-1.44],1.2581587578802326e-14
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,19758,1185,1.21 [1.06-1.39],0.0049181779523159
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,19922,110,1.56 [1.09-2.22],0.0152659365879277
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,17642,1044,1.62 [1.44-1.82],3.4635057813184366e-16
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,17005,1263,1.53 [1.37-1.71],7.349993226401896e-14
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,16653,272,1.62 [1.30-2.03],2.496802188077545e-05
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,13056,2274,1.31 [1.20-1.44],1.4415180804443502e-08
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,16602,404,1.56 [1.28-1.89],7.727543865982373e-06
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,19974,1401,1.22 [1.08-1.38],0.0018913905094065
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Mycoses,20081,524,1.46 [1.23-1.74],1.5388522074854236e-05
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,19334,1013,1.35 [1.19-1.55],7.787956446475341e-06
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,20020,1153,1.53 [1.37-1.71],5.875543284901143e-14
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,18778,205,1.44 [1.09-1.92],0.0108292079502664
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,20130,52,1.46 [0.84-2.53],0.1796518046080036
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Other septicaemia,19875,1008,1.57 [1.39-1.76],4.405459928564302e-14
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,19876,64,1.31 [0.76-2.27],0.3305756737842137
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Other viral diseases,20074,114,1.41 [0.96-2.08],0.0807324301554443
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",20059,99,1.22 [0.76-1.95],0.4087486180760478
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,18714,393,1.48 [1.21-1.80],9.287293650745504e-05
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,18578,257,1.25 [0.94-1.67],0.1235269241116586
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,18675,102,1.43 [0.94-2.15],0.0910088993862057
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,20115,48,1.38 [0.76-2.48],0.2865370837769935
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,20069,154,1.17 [0.80-1.70],0.4179169803727948
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Viral warts,19965,50,0.91 [0.42-1.97],0.8060681287628755
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],19987,72,1.13 [0.64-1.99],0.6758759323352224
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,Benign lipomatous neoplasm,19878,229,0.57 [0.37-0.89],0.0128618869711743
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,20055,37,1.49 [0.79-2.83],0.2203249897566978
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,20040,41,0.32 [0.10-1.05],0.0594794314013767
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,9518,71,0.57 [0.26-1.27],0.1718230652113163
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",19729,1439,0.90 [0.77-1.04],0.1462171643526407
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,Benign neoplasm of meninges,20116,58,0.80 [0.37-1.73],0.5681728107424353
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,20050,72,1.79 [1.24-2.59],0.0018763474407168
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,20106,104,0.92 [0.54-1.59],0.7759847266583072
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,Benign neoplasm of ovary,10560,65,1.25 [0.72-2.19],0.4272368209398829
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,Benign neoplasm: Ascending colon,20095,386,0.93 [0.71-1.24],0.63683968014791
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,Benign neoplasm: Caecum,20108,328,0.91 [0.67-1.24],0.563994059428861
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",20002,76,0.60 [0.28-1.29],0.1928275357833252
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,Benign neoplasm: Descending colon,20093,223,1.07 [0.76-1.50],0.6880638665072794
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,Benign neoplasm: Rectum,20049,351,1.01 [0.77-1.34],0.9211013569929932
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,19994,599,0.81 [0.64-1.03],0.091670688608071
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,Benign neoplasm: Transverse colon,20086,457,1.03 [0.81-1.31],0.8152887481305118
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,Carcinoma in situ of breast,7945,46,1.55 [0.88-2.74],0.1311538529241416
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",7977,55,1.57 [0.94-2.63],0.0863368053648463
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",14421,64,2.54 [1.95-3.31],4.245804206276252e-12
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",14442,85,1.26 [0.77-2.04],0.3581791683759315
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",20079,110,1.56 [1.10-2.21],0.013120300068621
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,"Haemangioma, any site",20080,107,1.33 [0.88-1.99],0.1731609789373001
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,Leiomyoma of uterus,10317,147,1.26 [0.87-1.81],0.2200243873870252
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,Lung cancer and mesothelioma,12831,432,1.38 [1.06-1.80],0.0178577398938477
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,Lymphoid leukaemia,14422,65,2.50 [1.91-3.28],3.6430168473817137e-11
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",14549,192,1.40 [1.04-1.90],0.0273238756389318
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",14621,264,1.16 [0.86-1.57],0.3194513764837245
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",8060,98,1.35 [0.87-2.09],0.1866882720549641
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",14454,97,1.52 [1.02-2.27],0.0388662112266023
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",14479,122,1.16 [0.75-1.81],0.5040578797438298
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",14468,111,1.12 [0.70-1.81],0.626330029121442
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",8042,80,1.11 [0.63-1.95],0.7161358880442266
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",14465,108,0.59 [0.31-1.12],0.1065855997439028
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",7224,829,1.06 [0.89-1.27],0.4926502712950363
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",14475,118,1.10 [0.69-1.75],0.7030451362008887
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",14439,82,0.77 [0.39-1.50],0.4443525621583487
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,14478,121,1.49 [1.04-2.13],0.028420757772529
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,Melanocytic naevi,20003,162,0.93 [0.61-1.43],0.7503130035617167
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,Melanocytic naevi of trunk,20106,68,0.97 [0.51-1.84],0.9358902528437674
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,Melanoma in situ,14404,100,1.15 [0.71-1.85],0.578940783048526
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",14463,106,1.24 [0.80-1.93],0.3359840346298571
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",14530,173,1.52 [1.14-2.02],0.0047963940318313
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",14656,299,1.17 [0.88-1.57],0.2785943990920312
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",14469,112,1.58 [1.12-2.23],0.0089881480154959
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,Other benign neoplasms of skin,19980,147,1.36 [0.97-1.91],0.0791544548649293
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",15628,1271,1.11 [0.97-1.28],0.1290245436702037
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",15696,1339,1.15 [1.01-1.31],0.0382035807711569
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,19868,330,1.63 [1.34-1.98],9.041463771273798e-07
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,18182,111,1.89 [1.40-2.55],3.219040753546467e-05
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,19598,60,1.87 [1.25-2.78],0.0022510264929286
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,19504,2942,1.35 [1.24-1.46],1.7180766513441467e-13
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,18700,60,1.35 [0.78-2.33],0.2868411120801455
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,19733,58,1.49 [0.90-2.48],0.1252601461209242
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,19716,1645,1.33 [1.20-1.48],1.3260786709251798e-07
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,19714,1643,1.33 [1.20-1.49],1.269072453441795e-07
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,18170,99,2.12 [1.65-2.73],4.186857385197557e-09
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,19824,1184,1.32 [1.17-1.50],1.4428035909414056e-05
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,19778,103,1.27 [0.82-1.95],0.2853117005466585
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,19598,60,1.51 [0.91-2.48],0.1074375128287562
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,19609,71,1.06 [0.57-1.96],0.8539874703803665
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,19970,295,1.49 [1.19-1.86],0.0005194749370061
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,20024,33,1.89 [1.14-3.15],0.0143994030013735
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",19915,240,1.61 [1.28-2.02],4.295655826594171e-05
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,18754,114,1.55 [1.09-2.19],0.0138225701896984
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,13612,339,1.60 [1.31-1.95],3.200912606491462e-06
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,18837,88,1.37 [0.74-2.52],0.3134476697934051
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,18842,93,1.51 [0.98-2.34],0.0600347774746397
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,13336,63,2.01 [1.43-2.81],5.070046104202445e-05
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,18748,44,1.40 [0.74-2.63],0.299376506290103
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,18118,271,1.40 [1.08-1.81],0.0113385730848929
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",19480,769,1.16 [0.97-1.37],0.0957130335391891
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,19127,416,1.00 [0.77-1.29],0.9990708055143798
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,18859,148,0.99 [0.64-1.54],0.9786150048707586
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,19900,1196,1.10 [0.96-1.28],0.1720507845181987
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,17038,1166,1.12 [0.97-1.29],0.1194754673752848
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",13344,71,1.74 [1.15-2.63],0.0090797738530504
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",18193,86,1.12 [0.66-1.92],0.6686718781785975
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,13579,306,1.24 [0.95-1.61],0.1163316123001843
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,13322,49,1.52 [0.89-2.58],0.1234411538979449
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,17196,3923,1.08 [0.99-1.17],0.066968360714979
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,13508,235,1.38 [1.05-1.81],0.0220659265171938
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,13877,604,1.25 [1.04-1.50],0.0196297741548237
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,20082,311,1.33 [1.04-1.69],0.0240797283070427
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,19895,124,1.85 [1.40-2.46],1.846558763816341e-05
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,13403,130,1.28 [0.87-1.88],0.2173869565548415
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",13342,69,1.34 [0.81-2.22],0.2542818782903994
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,19582,1475,1.17 [1.03-1.33],0.0135801014845059
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,13592,319,1.76 [1.46-2.13],4.772606367174713e-09
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,13604,331,1.64 [1.34-2.00],1.1067417750423124e-06
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",14011,738,1.10 [0.91-1.33],0.3066181845446029
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,13404,131,1.43 [1.01-2.02],0.0420221624487927
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,19889,118,1.86 [1.40-2.48],2.016903326912761e-05
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,14037,764,1.26 [1.08-1.48],0.0042700641878114
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,13828,555,1.36 [1.14-1.63],0.0005764208536286
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,17908,61,1.84 [1.21-2.79],0.0042954549253564
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,18787,5514,1.15 [1.08-1.23],1.434784926693532e-05
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,18157,50,1.10 [0.53-2.26],0.8015927403275978
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,18153,46,1.30 [0.67-2.52],0.4325764129278663
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,19982,1591,1.03 [0.90-1.17],0.700487528322659
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",19980,1589,1.03 [0.90-1.17],0.7046726179809791
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,18162,55,0.82 [0.37-1.81],0.6180030180155303
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,19825,978,1.00 [0.85-1.19],0.970531944843279
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",15152,1879,1.39 [1.26-1.53],2.1054696215648988e-11
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,20119,253,1.70 [1.37-2.11],1.2204204151194317e-06
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,18809,98,1.56 [1.07-2.26],0.0197277172790274
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,18950,103,1.21 [0.77-1.90],0.4079030688191758
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,18990,143,0.77 [0.46-1.27],0.2992450916327652
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",13439,166,1.25 [0.89-1.76],0.2026720383240426
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,17735,159,1.36 [0.97-1.90],0.0758275626186057
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,2140,84,1.67 [1.09-2.55],0.0190154350422495
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,2278,254,1.43 [1.08-1.89],0.0115381544789792
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,17647,71,2.13 [1.58-2.87],6.070842414579907e-07
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,2106,51,2.55 [1.74-3.72],1.265638830262491e-06
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,19425,1849,1.08 [0.96-1.21],0.2113283587839084
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,19219,508,1.16 [0.94-1.43],0.1714159981201689
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,18219,372,1.34 [1.07-1.69],0.0115881941195125
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,14182,909,1.41 [1.24-1.62],4.19297525133371e-07
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",20013,264,1.06 [0.78-1.45],0.699429615261168
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),18871,230,1.13 [0.81-1.56],0.4742054637047467
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Angina pectoris,17452,1317,1.19 [1.05-1.36],0.0074685813224598
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Aortic aneurysm,18960,319,1.24 [0.96-1.60],0.0975413380818283
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,18711,70,1.81 [1.22-2.69],0.0032540213194878
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",18879,238,1.38 [1.05-1.82],0.0209280731582894
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,10283,2408,1.28 [1.16-1.40],5.605293796883361e-07
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,AV-block,15418,564,1.26 [1.05-1.52],0.0117810326843909
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",20058,477,1.19 [0.97-1.48],0.1019447508661423
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Cardiac arrest,8101,226,1.74 [1.35-2.24],2.058785146711552e-05
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Cardiomyopathy,15033,179,1.14 [0.79-1.63],0.4883866787560078
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",14945,91,1.21 [0.75-1.97],0.4315377844873714
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,20124,63,1.30 [0.74-2.29],0.3570389480359671
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Conduction disorders,16161,1307,1.27 [1.12-1.43],0.000131637754192
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,18474,2361,1.20 [1.09-1.32],0.000282222407618
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,16309,7735,1.12 [1.06-1.19],0.0001012219663447
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,DVT of lower extremities,18787,290,1.06 [0.79-1.43],0.6900726117878737
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Endocarditis,14933,79,1.56 [1.05-2.33],0.0293626665241372
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,"Heart failure, strict",19880,1396,1.44 [1.29-1.60],4.2554444218742146e-11
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Hypertension,17369,6847,1.09 [1.02-1.16],0.0065768291401345
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,"Hypertension, essential",17373,6851,1.09 [1.03-1.16],0.0058285352545028
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,"Hypertension, portal",19983,85,1.98 [1.47-2.67],6.4274712154678e-06
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",10768,246,1.64 [1.31-2.06],1.4202488268772472e-05
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,10652,130,2.29 [1.85-2.84],2.838942418762993e-14
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Hypotension,19975,1340,1.41 [1.26-1.58],1.140160421444108e-09
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,19040,124,0.76 [0.44-1.31],0.3154255449713144
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",18629,2494,1.19 [1.08-1.31],0.0003519105548438
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",19701,677,1.07 [0.88-1.30],0.4734298624269926
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Left bundle-branch block,15286,432,1.31 [1.07-1.62],0.0090777620741641
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,19564,904,1.26 [1.09-1.46],0.0022876337737208
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",16912,777,1.33 [1.13-1.55],0.0004589132899266
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",20018,167,1.21 [0.84-1.73],0.3075943788312295
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",20091,347,1.26 [0.99-1.61],0.0582674301320731
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Oesophageal varices,18556,59,1.85 [1.25-2.75],0.002183552045777
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Other aneurysm,18727,86,1.46 [0.95-2.25],0.0840802579456406
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Other arrhythmias,15358,504,1.27 [1.04-1.54],0.0179183526937244
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,18753,112,1.90 [1.41-2.55],2.1513542575970303e-05
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,18916,275,1.76 [1.45-2.13],1.5253300582770818e-08
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,15047,193,1.16 [0.83-1.64],0.3860337088266152
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Other disorders of veins,18586,89,1.70 [1.18-2.45],0.0045492706599357
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,18536,39,1.64 [0.93-2.86],0.0849463368205802
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,18405,75,1.06 [0.60-1.88],0.8336191702692908
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,18641,144,1.32 [0.91-1.92],0.1422717788189285
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,16063,1209,1.26 [1.10-1.43],0.0005006980755834
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,18687,52,1.82 [1.15-2.86],0.0102826126093323
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,19255,614,1.36 [1.15-1.62],0.000466612749802
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,19466,469,1.57 [1.32-1.86],4.1410715453999313e-07
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",19144,814,1.09 [0.92-1.30],0.3336622102320114
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,8226,351,1.48 [1.19-1.84],0.0003980212959257
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Peripheral artery disease,19108,499,1.50 [1.26-1.78],7.082340017389398e-06
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),18861,364,1.02 [0.77-1.34],0.8986507455615849
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Pulmonary embolism,19507,510,1.35 [1.12-1.63],0.0016728803284483
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,20039,820,1.29 [1.10-1.50],0.0013495460514212
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Right bundle-branch block,15291,437,1.34 [1.09-1.63],0.0043100490713274
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Secondary right heart disease,19461,464,1.58 [1.33-1.88],2.798066574891091e-07
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,18547,217,1.49 [1.15-1.93],0.0024433297949589
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",19685,769,1.03 [0.86-1.25],0.7220400625334207
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",19673,801,1.08 [0.91-1.29],0.3803275865000679
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,19014,50,1.68 [1.04-2.71],0.0331545728100447
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,18725,84,1.32 [0.83-2.10],0.2428508743441003
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Transient ischemic attack,19292,268,1.00 [0.73-1.38],0.9781080918162334
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,18940,280,1.38 [1.08-1.77],0.0097209183531759
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Varicose veins,18931,434,0.99 [0.77-1.28],0.9312306397169756
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,18656,98,0.79 [0.43-1.44],0.4364985304383783
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Venous thromboembolism,19886,805,1.15 [0.97-1.37],0.0992939289590935
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",20058,289,1.20 [0.91-1.58],0.1938465472668968
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",17301,1192,1.05 [0.91-1.22],0.4900533901179986
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter V Mental and behavioural disorders,Any mental disorder,19683,3574,1.12 [1.03-1.22],0.0059630901682983
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",20033,340,1.18 [0.91-1.53],0.2093125416858031
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",17325,1216,1.12 [0.98-1.29],0.101318906984202
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",16173,64,1.27 [0.73-2.23],0.3999711581313575
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter V Mental and behavioural disorders,Smoking dependency,19692,999,1.31 [1.11-1.54],0.0012679092370815
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",17349,1240,1.25 [1.10-1.43],0.000745640157141
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter V Mental and behavioural disorders,Vascular dementia,19409,200,1.04 [0.72-1.50],0.8314427776257488
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Alzheimer disease,20127,511,0.97 [0.77-1.23],0.8021944103513583
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,"Alzheimer√ïs disease (Atypical or mixed), excluding more controls",12551,98,1.38 [0.90-2.10],0.135854242385689
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Bell's palsy,18561,73,1.72 [1.16-2.56],0.0069106200807503
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,18913,425,0.92 [0.70-1.21],0.5476375469753909
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Cerebral cysts,19756,208,1.24 [0.91-1.70],0.1712978627807307
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,20063,329,1.34 [1.05-1.70],0.0165640350035795
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,19421,72,1.19 [0.69-2.05],0.5264746325987157
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,20111,62,1.91 [1.32-2.77],0.0006172188548803
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",19618,70,1.40 [0.86-2.28],0.1782564907239602
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Epilepsy,18859,251,1.09 [0.80-1.49],0.580892981366068
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,19740,1132,1.14 [0.99-1.32],0.0668545608699316
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,20078,545,1.01 [0.81-1.26],0.9255211711277216
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Falls/tendency to fall,19561,2888,1.15 [1.06-1.26],0.001466673455769
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Generalized epilepsy,19816,45,0.95 [0.42-2.15],0.8940687155382468
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Hemiplegia,20003,269,1.29 [0.98-1.69],0.069571108171121
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Hydrocephalus,19608,60,0.78 [0.36-1.69],0.5295814167403026
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,20115,57,1.62 [1.03-2.57],0.038417235326939
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,18550,62,0.86 [0.42-1.78],0.6884932843236904
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,18550,62,1.16 [0.63-2.11],0.6360355876929069
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Memory loss,19190,132,0.96 [0.61-1.53],0.8760011525312893
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Migraine,18847,239,1.37 [1.05-1.79],0.0213321934454424
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",20084,218,1.38 [1.04-1.82],0.0235757182746484
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Motor neuron disease,12640,165,1.07 [0.72-1.59],0.7331665819106301
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,20018,52,1.18 [0.62-2.26],0.6162996658780898
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",19523,1035,1.11 [0.96-1.30],0.1700261444686964
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Neurological diseases,18862,3567,1.14 [1.05-1.24],0.001364058644863
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,19595,246,1.15 [0.85-1.56],0.372046226262999
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",18826,338,1.06 [0.81-1.40],0.6542142706066306
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",20058,292,1.44 [1.15-1.81],0.0017970063758245
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,15272,818,1.15 [0.97-1.36],0.1084566449676369
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,19617,69,1.05 [0.57-1.93],0.8853106255248395
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Other disorders of nervous system,19681,133,1.01 [0.64-1.59],0.9592903129682108
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,19715,182,0.94 [0.63-1.41],0.763509881067034
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Other facial nerve disorders,18568,80,1.65 [1.12-2.44],0.0117548625601311
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Other headache syndromes,18654,46,1.81 [1.13-2.88],0.0134134341646347
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Other neurological diseases,20033,485,1.15 [0.93-1.43],0.2029102454542133
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Other sleep disorders,19035,427,1.10 [0.86-1.40],0.4395799563786463
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Parkinson's disease,20096,344,1.04 [0.79-1.37],0.7810185720776553
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,19587,39,1.18 [0.56-2.46],0.6622514432548475
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Restless leg syndrome,20126,79,0.74 [0.37-1.48],0.3945355832788429
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Sleep apnoea,19940,368,1.12 [0.87-1.44],0.3931576594547399
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Small fibre neuropathy,19818,52,1.37 [0.79-2.39],0.2604747177910695
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,20115,186,1.07 [0.74-1.54],0.727865345655434
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,18551,63,1.16 [0.63-2.12],0.6297412564796911
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,20127,516,0.97 [0.77-1.23],0.8169219697124278
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),19353,194,1.05 [0.72-1.51],0.8085183320911251
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,19582,131,1.24 [0.84-1.83],0.2816556798844445
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,19748,489,0.92 [0.72-1.18],0.5102232506343158
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,19923,225,1.31 [0.98-1.76],0.0639513809598875
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,19062,58,0.77 [0.35-1.71],0.5266758971308376
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,19040,36,1.07 [0.47-2.47],0.8668638974861892
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",20022,63,1.89 [1.29-2.75],0.0010095840992683
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,19854,195,1.04 [0.72-1.50],0.849849370045458
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",2109,53,2.64 [1.86-3.75],5.7601032200619295e-08
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,2593,95,1.76 [1.21-2.55],0.0029755702560288
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,19544,93,1.14 [0.69-1.88],0.6165543277165706
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,19892,1227,1.10 [0.95-1.27],0.1879507814392627
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",19764,760,1.09 [0.91-1.31],0.3502580426835349
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,19262,258,1.02 [0.73-1.41],0.9146131303935296
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",20072,813,0.97 [0.80-1.17],0.7436455737455884
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,20121,70,1.21 [0.70-2.09],0.4968702965902114
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,20018,759,0.91 [0.75-1.12],0.3796599573867533
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",20093,434,0.87 [0.66-1.15],0.3252844079004873
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,20025,196,1.16 [0.82-1.63],0.397975010831654
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,19092,88,1.21 [0.73-2.00],0.4537612543117659
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,19092,88,0.89 [0.48-1.64],0.7046829445026608
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,19070,66,1.08 [0.58-2.01],0.819306135503916
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,20009,869,1.03 [0.86-1.22],0.7546067196289881
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,19378,238,1.20 [0.89-1.62],0.2315310388467441
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,19319,60,0.34 [0.13-0.91],0.031231525474301
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,19769,110,0.62 [0.33-1.15],0.1308165219908345
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,19994,335,0.96 [0.72-1.29],0.8095962587004775
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,19448,189,0.95 [0.64-1.40],0.7799391575081831
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,19949,120,0.85 [0.51-1.44],0.5496138915359869
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,19703,563,1.10 [0.90-1.36],0.3534366040803987
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,19589,138,1.18 [0.79-1.76],0.4122807790031102
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,18021,2797,1.05 [0.95-1.16],0.3263592627963219
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,19958,299,0.98 [0.72-1.34],0.9205746004931856
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,20111,164,1.52 [1.13-2.04],0.0058520587499619
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,19472,468,1.18 [0.94-1.46],0.1482576619608694
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,19740,81,0.65 [0.31-1.32],0.2306999878143116
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,20113,62,0.96 [0.49-1.90],0.9151078494522888
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,19114,110,0.73 [0.41-1.32],0.3028914161398801
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,19159,155,1.35 [0.97-1.90],0.0775794614391451
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,18807,142,1.30 [0.91-1.88],0.1527414673031292
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,19307,48,1.61 [0.97-2.66],0.062918877368856
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",18732,67,1.14 [0.63-2.06],0.6737577018044918
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,19242,102,0.67 [0.36-1.25],0.2099357627165975
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",19390,250,0.95 [0.67-1.33],0.753477270701095
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,19136,132,1.03 [0.65-1.61],0.9103598207795132
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,18745,80,1.14 [0.67-1.93],0.6261792759116951
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,18773,108,1.20 [0.77-1.86],0.4129855147211259
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,17561,2337,1.00 [0.90-1.11],0.9652696565765428
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,19086,82,1.33 [0.83-2.15],0.2355251428054085
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,19883,432,1.17 [0.93-1.47],0.1720874371847628
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,19518,67,1.46 [0.89-2.39],0.1297800271912128
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),19617,166,1.14 [0.78-1.66],0.5049066369625879
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,19925,96,1.22 [0.76-1.95],0.4085111141509912
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,20090,120,1.13 [0.73-1.76],0.5870891137501093
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,20012,100,1.20 [0.75-1.92],0.4524835634031485
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,19888,59,1.15 [0.62-2.14],0.65677462403783
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VIII Diseases of the ear and mastoid process,M¬éni¬ère disease,19891,62,1.08 [0.57-2.03],0.8224973614280768
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,20030,1032,1.15 [0.99-1.34],0.062593841744588
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,19780,782,1.14 [0.96-1.36],0.1342936415761037
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,19127,129,1.25 [0.84-1.86],0.2651719285274347
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,19075,77,1.18 [0.69-2.04],0.5419320160111605
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Acute pharyngitis,19956,53,1.75 [1.11-2.76],0.0157040391416648
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,20060,157,1.45 [1.06-1.99],0.0217674630668144
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,19956,53,1.36 [0.77-2.42],0.2928840273407231
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,All influenza,17868,131,1.47 [1.04-2.07],0.0305742595612365
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),17865,128,1.42 [0.99-2.04],0.0598007796907491
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Allergic asthma (mode),12484,85,0.94 [0.51-1.73],0.8312351568365829
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Allergic rhinitis,20041,207,1.19 [0.86-1.64],0.2895329515785517
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",13585,1510,1.17 [1.03-1.33],0.0140487026913955
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",13890,1491,1.17 [1.03-1.32],0.0170229352873314
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),19680,153,1.21 [0.83-1.77],0.3118885348230348
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",17823,86,1.19 [0.71-1.99],0.5160335710358321
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Bronchiectasis,16856,441,1.45 [1.20-1.74],8.38698746620925e-05
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",16477,62,1.36 [0.79-2.33],0.2685673244918509
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,19155,2740,1.18 [1.08-1.29],0.0003222328297516
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",19066,68,0.98 [0.51-1.85],0.9389865677752602
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Chronic sinusitis,19114,116,0.90 [0.54-1.51],0.6917410763623356
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",19878,1392,1.22 [1.08-1.39],0.0018406973085238
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Deviated nasal septum,19070,72,1.05 [0.58-1.91],0.8721361986278087
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,18267,5256,1.23 [1.15-1.31],3.2753622802154987e-10
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",19295,297,1.36 [1.06-1.74],0.0138104312510702
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Early onset COPD,18588,102,1.72 [1.23-2.40],0.0015587612333139
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Emphysema,16794,379,1.38 [1.11-1.72],0.0038139849687079
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,18979,408,1.59 [1.32-1.90],8.061270153122008e-07
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Influenza and pneumonia,19897,2160,1.43 [1.31-1.56],8.52822137628832e-16
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Interstitial lung disease,19015,444,1.57 [1.31-1.87],8.249792277608691e-07
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Later onset COPD,19665,1290,1.17 [1.02-1.34],0.023149125587842
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,20111,394,1.37 [1.11-1.69],0.0033650307446788
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Nasal polyp,19084,86,1.12 [0.66-1.89],0.674101648477162
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,19884,1087,1.40 [1.23-1.59],2.591759393009103e-07
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Other diseases of pleura,19881,2302,1.32 [1.21-1.44],1.5874386737752103e-09
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,19655,657,1.14 [0.94-1.37],0.1808092895936887
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Other pleural conditions,17634,55,1.46 [0.87-2.46],0.1528936318906923
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,20010,523,1.58 [1.35-1.86],1.6422955560275392e-08
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,20013,1476,1.33 [1.19-1.49],4.655540987117522e-07
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Pleural effusion,18721,1142,1.48 [1.32-1.66],9.330885579756251e-12
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Pleural plaque,17805,226,1.34 [1.01-1.78],0.0434304870835818
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",19652,1915,1.46 [1.34-1.60],2.1862871958574074e-16
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,20011,294,1.25 [0.96-1.62],0.1025513048049484
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Pneumothorax,17731,152,1.12 [0.75-1.67],0.58487781988166
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Pollen allergy,20118,175,1.10 [0.76-1.60],0.6055786118431836
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Pulmonary oedema,19564,77,1.76 [1.21-2.55],0.0029263955383539
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Respiratory insufficiency,12461,62,1.90 [1.25-2.87],0.0024195545448101
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,19868,1071,1.40 [1.23-1.59],3.019607871972318e-07
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,19206,208,1.18 [0.86-1.64],0.3038581253982342
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Viral pneumonia,17986,249,1.44 [1.12-1.86],0.0052155645935249
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",19693,199,1.36 [1.00-1.84],0.0478718451334036
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,6487,103,1.75 [1.23-2.50],0.001838905633104
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,12875,52,1.65 [1.02-2.67],0.0426750419122234
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Acute appendicitis,20027,112,1.01 [0.61-1.66],0.9716792372533148
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Acute gastritis,14073,86,1.12 [0.66-1.90],0.6763244506618276
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Acute pancreatitis,18397,167,1.11 [0.76-1.63],0.5916566200386397
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Acute peritonitis,19709,93,1.32 [0.84-2.08],0.2275810091728098
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Alcoholic liver disease,19281,51,2.18 [1.53-3.11],1.559607258809169e-05
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Barrett oesophagus,14421,434,0.97 [0.75-1.25],0.8171562609430199
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",18355,125,1.56 [1.12-2.18],0.0087078793450573
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",19767,125,1.52 [1.09-2.12],0.0138993138181182
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Cholecystitis,18416,186,1.27 [0.91-1.77],0.1670598240465867
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Cholelithiasis,19128,898,1.39 [1.21-1.60],2.158801478161123e-06
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Chronic gastritis,14282,295,0.92 [0.67-1.27],0.6183660245031999
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Chronic pancreatitis,18276,46,1.64 [0.96-2.81],0.0702236013958261
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",20007,109,1.75 [1.29-2.39],0.0003823694558606
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Coeliac disease,18643,106,1.42 [0.97-2.07],0.0704353536173198
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Collagenous colitis,18613,89,1.30 [0.81-2.08],0.270112464862635
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,20025,147,1.02 [0.66-1.57],0.9328673560432664
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Constipation,19882,1778,1.02 [0.90-1.15],0.7895110504202274
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Crohn disease,18594,70,0.96 [0.50-1.85],0.9093894934501257
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",19823,55,0.91 [0.43-1.93],0.7983575634831568
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Crohn's disease NAS,18588,64,0.94 [0.47-1.88],0.8620493170951369
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Dental caries,19589,162,1.42 [1.03-1.96],0.0302323686483961
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,17435,2200,1.10 [0.99-1.23],0.0746323637672592
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Diseases of appendix,20052,137,0.99 [0.63-1.56],0.9757005257960072
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Diseases of liver,20029,799,1.31 [1.13-1.53],0.0005313696600129
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",17935,3948,1.06 [0.97-1.14],0.1860051629518826
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",19835,408,1.24 [0.99-1.55],0.0618804973557811
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Diseases of peritoneum,20052,436,1.23 [0.99-1.52],0.0667224374087059
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,19508,81,0.85 [0.45-1.61],0.616749638744075
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Diseases of salivary glands,19400,47,0.89 [0.39-2.03],0.7751247629833639
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Diseases of the digestive system,19849,1312,1.30 [1.16-1.47],1.539709880230304e-05
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Diseases of tongue,19410,81,1.51 [0.99-2.31],0.0582115784130301
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",19534,1304,1.33 [1.18-1.50],2.7683835576141607e-06
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,16089,3266,1.04 [0.96-1.14],0.3316781305532328
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Duodenal ulcer,14192,205,1.49 [1.14-1.95],0.0034569897710637
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",20038,166,1.41 [1.03-1.93],0.0307498780960411
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,20098,19,1.76 [0.83-3.71],0.1396078674793784
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,19358,128,1.74 [1.31-2.32],0.0001529226805846
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,12921,98,1.11 [0.67-1.85],0.681140845981414
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Functional dyspepsia,14472,485,0.87 [0.67-1.12],0.2777051886201999
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Gastric ulcer,14352,365,1.32 [1.05-1.65],0.017831746338765
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,16277,2290,0.99 [0.89-1.11],0.8735927113138013
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,14537,550,1.32 [1.10-1.59],0.0027359891870619
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,14613,7124,1.14 [1.07-1.20],1.5223514231043594e-05
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,GI-bleeding,19615,1078,1.30 [1.14-1.49],8.261095042578199e-05
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,19472,45,1.36 [0.73-2.56],0.3347517551169354
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,13679,1021,1.13 [0.98-1.32],0.0946676700746295
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",19290,60,2.14 [1.54-2.97],5.804011767881667e-06
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Hernia,18357,3122,1.11 [1.01-1.21],0.029256746003116
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Impacted teeth,20100,18,1.81 [0.86-3.84],0.1197022797816826
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Impaction of intestines,12889,66,0.60 [0.27-1.35],0.2161052411822064
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Inguinal hernia,16177,942,1.15 [0.98-1.35],0.0966041731103322
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",15337,102,0.72 [0.38-1.34],0.297674421857722
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,12920,97,1.24 [0.79-1.95],0.343333435487238
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Intestinal malabsorption,18661,124,1.34 [0.93-1.94],0.1216361254830432
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,13264,441,1.07 [0.84-1.35],0.5946853494244764
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,20106,283,1.28 [0.98-1.68],0.0673305264551706
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,19203,679,1.43 [1.23-1.67],5.137640889898152e-06
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,19468,944,1.36 [1.18-1.56],1.142704051154369e-05
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Oesophageal obstruction,14172,185,1.21 [0.87-1.69],0.2568167197909803
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Oesophagitis,14595,608,1.05 [0.86-1.29],0.6152463757368313
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,20076,116,1.45 [1.00-2.10],0.0477270201315864
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,15305,70,1.00 [0.52-1.90],0.9914255849800244
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,14014,1191,1.12 [0.97-1.29],0.1092918204748564
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,18534,304,1.13 [0.85-1.50],0.3965942666828477
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,18356,126,1.18 [0.77-1.81],0.4366778843120311
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Other diseases of intestine,14490,1667,1.07 [0.95-1.22],0.2591499366305236
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Other diseases of intestines,18131,5308,1.06 [0.99-1.14],0.0759735895680357
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,19380,186,1.30 [0.94-1.79],0.1140262109016549
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Other diseases of liver,19888,658,1.25 [1.04-1.49],0.015240706878954
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,14653,666,1.16 [0.97-1.39],0.1103278374305586
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Other diseases of pancreas,18409,179,1.10 [0.76-1.60],0.6203175329583824
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,19987,371,1.17 [0.92-1.49],0.2075394112053183
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,14928,941,1.29 [1.12-1.49],0.0003141245881667
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,19627,1090,1.31 [1.15-1.49],6.155265459642036e-05
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,19577,150,1.02 [0.66-1.56],0.9350674543214016
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,14640,1817,1.05 [0.93-1.18],0.4196613907278668
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),15855,1868,1.13 [1.01-1.26],0.0289552301592858
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,19328,98,1.46 [0.98-2.18],0.0635646172796541
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,19362,838,1.40 [1.21-1.61],3.4269305698049337e-06
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",13201,378,0.95 [0.72-1.25],0.6951901233007607
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,20095,23,1.68 [0.83-3.41],0.1509474129433716
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,13350,527,1.08 [0.87-1.34],0.5093779171887178
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",18681,144,1.27 [0.88-1.85],0.2001690037242009
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Recurring oral aphthae,20115,46,1.41 [0.76-2.61],0.2750904616982572
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,19422,88,1.08 [0.63-1.85],0.7894810467395499
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Toxic colitis,18596,72,1.25 [0.73-2.14],0.4232984159373518
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,14288,301,1.10 [0.83-1.46],0.5176431080190782
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Ulcerative colitis,18666,142,0.89 [0.56-1.44],0.6413023873158243
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",18638,114,0.87 [0.51-1.49],0.610147165539443
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Umbilical hernia,15459,224,0.78 [0.52-1.17],0.2291279008289728
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,13031,208,1.27 [0.94-1.72],0.1246601538025327
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Ventral hernia,15469,234,1.36 [1.03-1.81],0.0317319151565146
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Volvulus,12901,78,1.49 [0.96-2.31],0.0753211286659685
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,20037,354,1.17 [0.91-1.50],0.2104145150263782
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,19815,62,1.29 [0.73-2.26],0.375928813604734
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,17965,143,1.15 [0.78-1.71],0.4806411914438137
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,19593,708,1.36 [1.16-1.59],0.0001565676117292
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",19008,123,1.42 [0.98-2.04],0.0627288479530511
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,18329,507,1.44 [1.20-1.72],5.812971805937709e-05
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,19825,269,1.27 [0.97-1.66],0.0883713543704441
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,20030,474,1.28 [1.04-1.57],0.0187329882329059
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,19601,45,1.21 [0.61-2.41],0.5788116603939053
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,18742,3189,1.15 [1.06-1.26],0.0008756782694809
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,19750,377,1.01 [0.77-1.32],0.9299662599520612
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,19634,261,1.04 [0.76-1.43],0.7910326733165597
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,19798,913,1.36 [1.18-1.56],1.771753815815394e-05
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",20110,52,0.63 [0.26-1.55],0.3173234590266301
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,17877,55,0.71 [0.30-1.65],0.4223582775788675
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,19428,55,0.97 [0.47-1.98],0.9314197854742514
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,19813,257,1.30 [0.99-1.71],0.054912417027541
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,18341,519,1.05 [0.84-1.31],0.6615878079522001
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,17901,79,1.50 [0.98-2.30],0.0626005622354533
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,20053,74,1.26 [0.74-2.11],0.3933526177720905
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,19067,182,1.55 [1.18-2.05],0.0019003285575363
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,19950,197,1.11 [0.78-1.58],0.5678357833346295
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,19631,75,1.21 [0.70-2.07],0.4945436968717732
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,17886,64,0.82 [0.39-1.71],0.5909490983470624
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,19595,1773,1.22 [1.10-1.36],0.0002483310256257
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",18377,555,1.04 [0.84-1.29],0.695578228047042
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,17904,82,1.50 [0.98-2.28],0.0618623285004032
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,20050,297,1.04 [0.77-1.41],0.7857462733038518
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,19622,66,1.55 [0.99-2.45],0.0580949923623072
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,19997,244,1.15 [0.85-1.57],0.3643027134351564
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,20066,383,1.14 [0.90-1.46],0.2758528920606011
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,17929,107,1.21 [0.78-1.88],0.3894105690841043
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,18106,284,1.07 [0.80-1.43],0.6605243290333521
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,20054,371,1.15 [0.90-1.47],0.2524241291351899
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",18093,271,1.61 [1.30-2.00],1.7459085839603438e-05
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,20103,124,1.18 [0.77-1.80],0.4497970387080904
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,16802,68,0.55 [0.24-1.27],0.1631117734895774
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,17755,5553,1.11 [1.04-1.19],0.0015911955338409
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,16534,4332,1.09 [1.01-1.18],0.0190687003632289
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,16780,46,0.64 [0.24-1.69],0.3682065807470738
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,16779,118,0.75 [0.43-1.31],0.3055345743869758
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,16821,160,1.30 [0.92-1.83],0.1417668593170997
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,19905,50,1.21 [0.63-2.33],0.5580083654648134
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",16787,126,1.19 [0.79-1.80],0.4074113810055022
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,13486,1284,1.02 [0.89-1.18],0.7527063209000371
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",19939,214,0.78 [0.52-1.17],0.2299888530873546
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,17139,478,1.07 [0.85-1.34],0.5857172713938115
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,16305,6944,1.10 [1.03-1.17],0.0026632424023055
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,17963,106,1.44 [0.99-2.10],0.0560323766462803
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,16887,153,1.67 [1.25-2.23],0.0005846118687264
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,17179,445,1.10 [0.86-1.39],0.4439066481615119
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,19310,2649,1.08 [0.98-1.19],0.1289979305395823
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,17009,275,1.04 [0.76-1.43],0.8130340452382329
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,16861,127,1.32 [0.89-1.97],0.1711692147355114
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,16838,104,1.11 [0.69-1.80],0.6600012070902359
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,19458,88,0.97 [0.54-1.71],0.905611013593362
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,13939,1737,1.12 [0.99-1.26],0.0670575068424211
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,12861,659,1.45 [1.24-1.70],4.6819778691235104e-06
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",20044,653,1.39 [1.18-1.63],6.324142725142411e-05
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,12265,63,1.20 [0.68-2.14],0.5267186957092005
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),12472,270,1.26 [0.96-1.65],0.0927489021812537
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,16960,226,1.08 [0.77-1.51],0.6679273906183396
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,12622,420,1.07 [0.84-1.37],0.5894454161552639
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,16729,68,1.56 [1.02-2.39],0.0402321293470594
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,17232,571,1.18 [0.97-1.44],0.0996168510151028
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,16916,255,0.88 [0.62-1.26],0.4924832378473892
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,12596,394,1.04 [0.80-1.35],0.7587660767964483
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,16795,61,1.42 [0.84-2.40],0.194671606443064
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",16782,48,1.64 [0.97-2.75],0.0626382296607586
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,17925,68,1.89 [1.33-2.68],0.000411296632614
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,19757,1900,1.12 [1.00-1.25],0.0427441079365085
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,19199,1342,1.08 [0.94-1.23],0.265911600593108
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",19983,469,1.26 [1.03-1.56],0.0266762459836839
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,14895,2693,1.17 [1.07-1.29],0.0005395528266734
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,12242,40,0.52 [0.17-1.56],0.2428887927086824
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,16821,87,1.04 [0.60-1.81],0.8973335954090937
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,12267,65,1.41 [0.88-2.27],0.1516188567238838
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),12320,118,1.46 [1.01-2.11],0.0448837402040852
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,18062,205,0.97 [0.67-1.41],0.8836460062914524
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,18273,416,1.11 [0.88-1.40],0.3797997243914025
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,20110,92,1.07 [0.64-1.80],0.79721662611447
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",18327,1666,1.03 [0.91-1.17],0.6416269478897865
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,16795,61,0.96 [0.48-1.92],0.8983487404404733
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),12333,131,1.03 [0.66-1.62],0.8888765734130739
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,17324,663,0.92 [0.75-1.14],0.4729607295790144
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,14082,1880,1.19 [1.07-1.32],0.001553785094134
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,19478,108,1.30 [0.85-1.98],0.2306810373967657
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,20120,59,1.30 [0.74-2.30],0.3622313352270422
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,16801,67,0.97 [0.49-1.91],0.9358284451221796
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",17874,1140,1.34 [1.17-1.52],1.2858794860634075e-05
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,16823,89,1.66 [1.13-2.42],0.0090692122791719
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,13992,1790,1.11 [0.99-1.25],0.0692127906863209
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,17961,104,0.97 [0.58-1.63],0.9202671670552576
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,16763,29,1.31 [0.60-2.87],0.4999698580951901
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,16829,168,1.23 [0.87-1.75],0.247870356611889
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,17308,574,1.30 [1.08-1.57],0.0061667226232594
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,19801,431,0.94 [0.73-1.23],0.6632800378538082
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,17210,549,1.04 [0.83-1.30],0.727829980566314
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,19994,464,1.28 [1.04-1.57],0.0193908436668376
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,20105,58,1.12 [0.58-2.15],0.7308090185603613
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,16874,140,1.05 [0.68-1.63],0.8173782840465968
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,15700,739,1.19 [1.00-1.42],0.0502236891848283
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,17273,539,1.36 [1.13-1.64],0.001350241548613
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],16982,248,1.11 [0.80-1.53],0.5352266725779007
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",12266,64,1.01 [0.52-1.95],0.973032854037734
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,14889,2687,1.18 [1.08-1.30],0.0002922836045103
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,12915,713,1.18 [0.99-1.41],0.0713776018531647
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,19692,322,0.82 [0.59-1.13],0.2206076974458625
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",20081,63,1.19 [0.67-2.12],0.5557044643993547
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",17834,59,0.96 [0.48-1.95],0.9191563972391622
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,12262,60,1.36 [0.78-2.38],0.2779742611964447
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,16754,93,0.91 [0.51-1.61],0.7337320528513448
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,12678,476,1.30 [1.06-1.60],0.0119218213497345
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,17024,290,1.17 [0.88-1.55],0.2821953596344329
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,16902,241,1.26 [0.94-1.68],0.1164234173048422
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,16880,219,1.12 [0.80-1.55],0.5083144845628118
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,14193,60,1.29 [0.73-2.30],0.3799138156186774
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",20109,62,0.99 [0.50-1.95],0.9700314971667988
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,17208,474,1.09 [0.86-1.37],0.4790107112298825
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sj¬ögren],19457,87,1.38 [0.89-2.15],0.1495296752261519
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,18993,2259,1.20 [1.08-1.32],0.0004205201267651
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",16862,128,1.13 [0.73-1.75],0.5887639140752634
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,17239,578,1.02 [0.83-1.27],0.8251552814223356
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,18927,230,1.11 [0.80-1.55],0.5188271821091324
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,16859,198,0.88 [0.59-1.31],0.5262364008295897
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,18326,1665,1.11 [0.99-1.26],0.0806707507723481
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,17748,1087,1.15 [1.00-1.33],0.0581581479478475
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],16783,49,1.26 [0.66-2.38],0.4821091668315688
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,19477,107,1.37 [0.91-2.07],0.1311297287514677
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,16883,149,1.23 [0.84-1.80],0.2904243843488749
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,16815,81,1.22 [0.72-2.07],0.4616578844468172
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),12265,63,1.42 [0.86-2.37],0.1729906704273943
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Acute renal failure,18976,1834,1.49 [1.35-1.63],8.82427933641333e-17
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),8122,23,0.77 [0.23-2.61],0.6713828006570964
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,10300,27,0.34 [0.08-1.41],0.1358812859917404
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,19848,265,1.00 [0.73-1.38],0.9802673061516916
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,19673,90,0.91 [0.50-1.64],0.7493033037211083
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,18905,1763,1.57 [1.44-1.72],1.234868258253662e-23
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,19943,89,2.46 [1.96-3.08],7.027918165679114e-15
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,19896,340,1.25 [0.98-1.60],0.069549679973198
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Cystitis,16897,262,1.19 [0.89-1.59],0.2518043764921118
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Dialysis,17213,71,2.68 [2.15-3.34],1.855993470997139e-18
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,8812,1828,1.04 [0.92-1.17],0.5746175056590053
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Disorders of breast,10382,109,0.84 [0.49-1.47],0.549292267762034
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Endometriosis,8134,35,1.09 [0.47-2.50],0.844215956458265
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,8593,494,0.95 [0.75-1.21],0.6893153630576653
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,16629,5329,1.19 [1.11-1.27],2.461264591176398e-07
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,19922,68,2.26 [1.69-3.03],4.3480297690010094e-08
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Hydrocele,7087,103,1.06 [0.65-1.73],0.8203942660334947
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,17170,282,1.06 [0.78-1.45],0.6923286297296352
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,8540,1556,1.05 [0.93-1.20],0.4281894885332715
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,10438,138,1.31 [0.90-1.90],0.1611439041242206
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),7090,106,1.24 [0.80-1.90],0.3325510002735137
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,16706,71,1.48 [0.93-2.33],0.0957570568777005
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,8987,888,1.00 [0.84-1.19],0.9799909376653844
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,7036,52,0.73 [0.31-1.72],0.46560730438756
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,8133,34,1.69 [0.91-3.13],0.0946336345966172
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",20121,75,1.25 [0.75-2.08],0.3937557425326299
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",20117,75,0.82 [0.42-1.61],0.5656217679671949
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,19100,2465,1.18 [1.08-1.30],0.0005090439899495
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,17445,810,0.97 [0.80-1.17],0.7221059764045075
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,10319,46,1.23 [0.62-2.44],0.5578447272385838
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,20064,508,1.32 [1.09-1.60],0.0044554137614262
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,7107,123,1.12 [0.72-1.74],0.6100153843586014
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,7122,138,1.30 [0.90-1.87],0.1603955125836725
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,7111,127,0.93 [0.57-1.52],0.7689856271514254
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,20096,70,0.86 [0.44-1.70],0.6734261210013853
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,18557,1922,1.29 [1.17-1.43],8.430060172593625e-07
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,10373,73,1.08 [0.60-1.95],0.8029882904729515
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,8163,64,0.88 [0.45-1.75],0.723969452769119
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",8234,135,1.07 [0.70-1.65],0.7535397521648648
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,8149,50,1.01 [0.50-2.06],0.968668899789439
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,8186,87,0.55 [0.27-1.13],0.1057507783830767
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,17220,332,1.22 [0.95-1.58],0.1256279006142747
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,19720,164,1.40 [1.02-1.92],0.0387276789610006
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,8205,106,1.06 [0.65-1.72],0.8230079710631142
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,8120,21,1.31 [0.52-3.30],0.5650303015639679
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,8287,188,0.76 [0.49-1.17],0.2112642155351194
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,8181,82,0.74 [0.38-1.44],0.3718009832165759
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,8281,182,0.98 [0.66-1.45],0.921179871488338
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,19902,48,1.53 [0.88-2.65],0.1291938116329537
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",7113,129,1.14 [0.75-1.73],0.5532477048472237
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,19916,3028,1.42 [1.32-1.53],9.54950558999644e-20
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",16965,77,2.05 [1.50-2.79],6.375979391539116e-06
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,17284,142,1.95 [1.52-2.48],8.692811411675985e-08
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,19617,34,0.67 [0.23-1.99],0.4734129000877136
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Urethral stricture,16864,229,1.02 [0.72-1.43],0.9283108996377504
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Urolithiasis,19924,341,0.95 [0.71-1.28],0.7562601253144224
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Uterine polyps,8132,33,0.39 [0.11-1.39],0.1448281342696957
